ConductScience.org, home

Gene · 5172

Papers3,149

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

161 to 180 of 3,149

Download this page as JSON
TitleJournalYearPMIDFound bySource
Comparative analysis of haplotypes carrying pathogenic variants c.1545T>G, c.2027T>A and c.919-2A>G of the SLC26A4 gene in patients with hearing loss from the Tyva Republic (Southern Siberia).Vavilovskii Zhurnal Genet Selektsii202540144368PubTator, text miningPubMed
Novel genetic determinants contribute to hearing loss in a central European cohort with enlarged vestibular aqueduct.Mol Med202540121402PubTator, text miningPubMed
Lmx1a is essential for marginal cell differentiation and stria vascularis formation.Front Cell Dev Biol202540109362PubTator, text miningPubMed
Clinical Exome Sequencing Identifies, Two Homozygous LOXHD1 Variants in Two Inbred Families With Pre-Lingual Hearing Loss From South India.Ann Hum Genet202540070250PubTator, text miningPubMed
Mutation spectrum of GJB2, SLC26A4 and mtDNA12SrRNA genes in non-syndromic hearing loss patients from Gansu, China.Int J Pediatr Otorhinolaryngol202540054393PubTator, text miningPubMed
[The study of detection and etiology of delayed sensorineural hearing loss in children].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi202540049644PubTator, text miningPubMed
Research hotspots and trends of the SLC26A4 gene-related hearing loss from the perspective of knowledge graph.Intractable Rare Dis Res202540046025PubTator, text miningPubMed
Advances in Understanding the Molecular Dynamics of Autosomal Dominant Auditory Neuropathy: Unveiling a Novel DIAPH3 Gene Variant Associated With Sensorineural Hearing Loss and Bilateral Vestibular Aqueduct Enlargement.
J Audiol Otol202540040362PubTator, text miningPubMed
The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss.Otolaryngol Head Neck Surg202540008839PubTator, text miningPubMed
Three- and four-stranded nucleic acid structures and their ligands.RSC Chem Biol202540007865PubTator, text miningPubMed
Unraveling the Genetic Landscape of Hearing Loss: A Comprehensive Study of Azeri Families in Ardabil, Iran.Mol Genet Genomic Med202539967327PubTator, text miningPubMed
Van Der Waals Hybrid Integration of 2D Semimetals for Broadband Photodetection.Adv Mater202539945105PubTator, text miningPubMed
[Application value of non-invasive prenatal diagnosis for recessive monogenic genetic diseases based on relative haplotype dosage changes].Zhonghua Yi Xue Za Zhi202539938985PubTator, text miningPubMed
Environmentally-friendly rGO/Mn nanocomposites for efficient removal of tetracycline and its degradation pathway.J Environ Manage202539862825PubTator, text miningPubMed
Newborn screening for common genetic variants associated with permanent hearing loss: Implementation in Ontario and review of the first 3 years.Genet Med202539846246PubTator, text miningPubMed
[Correction of the pathogenic mutation in the deafness gene SLC26A4 via prime editor and adenine base editor in vitro].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi202539842828PubTator, text miningPubMed
Comprehensive analysis of metabolomics and transcriptomics reveals varied tepal pigmentation across Gloriosa varieties.BMC Plant Biol202539819392PubTator, text miningPubMed
Transcriptomic landscape of hyperthyroidism in mice overexpressing thyroid-stimulating hormone.iScience202539811643PubTator, text miningPubMed
Genetic and audiological determinants of hearing loss in high-risk neonates.Braz J Otorhinolaryngol202539754783PubTator, text miningPubMed
Hearing loss trajectory and prediction model for children with enlarged vestibular aqueduct.Am J Otolaryngol202539740534PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5172/papers?page=9